利伐沙班片是抗凝血药物吗,有溶栓作用吗？

Non-valvular atrial fibrillation (NVAF) is an important type of cardiac arrhythmia, and its incidence gradually increases with age. The elderly are the main affected population of NVAF. NVAF often leads to arterial embolism and increases the risk of stroke. Data show that NVAF is an important factor leading to stroke in elderly patients. Anticoagulation is an important method in the clinical treatment of NVAF. (Rivaroxaban) is a new coagulation factor Xa inhibitor that can directly inhibit coagulation factor Xa to achieve anticoagulation purposes. At present, rivaroxaban has been widely used abroad. So, are rivaroxaban tablets an anticoagulant drug and do they have thrombolytic effect?

Is Rivaroxaban an anticoagulant drug?

Rivaroxaban is a new type of anticoagulant drug. Rivaroxaban has high selectivity for factor Xa. It can competitively inhibit factor Xa, combine with its active site, reduce its activity, interrupt the endogenous and exogenous coagulation cascade, and inhibit thrombin generation and thrombosis. Rivaroxaban can directly inhibit factor Xa without the action of antithrombin III.

Rivaroxaban can inhibit the generation of thrombin, but has no effect on the existing thrombin activity and will not reduce the body's normal physiological hemostasis function. Rivaroxaban can also inhibit prothrombin, prolong prothrombin time, and activate partial prothrombin time.

Does Rivaroxaban tablets have thrombolytic effect?

No, Rivaroxaban is a new type of oral anticoagulant that does not have a thrombolytic effect. This drug can prevent the formation of new thrombi on the basis of old thrombi, but it cannot remove existing thrombi.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: